{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T22:17:46Z","timestamp":1768083466422,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81200033"],"award-info":[{"award-number":["81200033"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81470243"],"award-info":[{"award-number":["81470243"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570041"],"award-info":[{"award-number":["81570041"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.chest.2016.03.007","type":"journal-article","created":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T04:58:38Z","timestamp":1458277118000},"page":"367-373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Elevated Levels of Circulating Bone Morphogenetic Protein 7 Predict Mortality in Pulmonary Arterial Hypertension"],"prefix":"10.1016","volume":"150","author":[{"given":"Dong","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing-Xiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie-Ming","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Cheng","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"25 suppl","key":"10.1016\/j.chest.2016.03.007_bib1","doi-asserted-by":"crossref","first-page":"D13","DOI":"10.1016\/j.jacc.2013.10.035","article-title":"Genetics and genomics of pulmonary arterial hypertension","volume":"62","author":"Soubrier","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.chest.2016.03.007_bib2","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1161\/01.CIR.0000012754.72951.3D","article-title":"Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor","volume":"105","author":"Atkinson","year":"2002","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.chest.2016.03.007_bib3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1183\/09031936.00187310","article-title":"Targeted gene delivery of BMPR2 attenuates pulmonary hypertension","volume":"39","author":"Reynolds","year":"2012","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.chest.2016.03.007_bib4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1161\/01.RES.0000200180.01710.e6","article-title":"Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension","volume":"98","author":"Teichert-Kuliszewska","year":"2006","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.chest.2016.03.007_bib5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1124\/mol.107.041673","article-title":"Functional characterization of bone morphogenetic protein binding sites and Smad1\/5 activation in human vascular cells","volume":"73","author":"Upton","year":"2008","journal-title":"Mol Pharmacol"},{"issue":"5","key":"10.1016\/j.chest.2016.03.007_bib6","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/ATVBAHA.107.141200","article-title":"Dysregulated bone morphogenetic protein signaling in monocrotaline-induced pulmonary arterial hypertension","volume":"27","author":"Morty","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5-6","key":"10.1016\/j.chest.2016.03.007_bib7","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.vph.2009.09.001","article-title":"Interaction between bone morphogenetic proteins and endothelin-1 in human pulmonary artery smooth muscle","volume":"51","author":"Din","year":"2009","journal-title":"Vascul Pharmacol"},{"issue":"8","key":"10.1016\/j.chest.2016.03.007_bib8","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1161\/CIRCRESAHA.107.165530","article-title":"Bone morphogenetic protein-9 is a circulating vascular quiescence factor","volume":"102","author":"David","year":"2008","journal-title":"Circ Res"},{"issue":"8","key":"10.1016\/j.chest.2016.03.007_bib9","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3109\/0886022X.2013.815106","article-title":"Bone morphogenetic protein-7 and disease progression in renal amyloidosis patients","volume":"35","author":"Denizli","year":"2013","journal-title":"Ren Fail"},{"issue":"25 suppl","key":"10.1016\/j.chest.2016.03.007_bib10","doi-asserted-by":"crossref","first-page":"D34","DOI":"10.1016\/j.jacc.2013.10.029","article-title":"Updated clinical classification of pulmonary hypertension","volume":"62","author":"Simonneau","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.chest.2016.03.007_bib11","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2353\/ajpath.2008.071030","article-title":"Bone morphogenetic proteins are overexpressed in the bone marrow of primary myelofibrosis and are apparently induced by fibrogenic cytokines","volume":"172","author":"Bock","year":"2008","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.chest.2016.03.007_bib12","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.athoracsur.2005.03.094","article-title":"Expression of bone morphogenetic proteins in human lung carcinomas","volume":"80","author":"Langenfeld","year":"2005","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.chest.2016.03.007_bib13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur Heart J"},{"issue":"14","key":"10.1016\/j.chest.2016.03.007_bib14","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMra040291","article-title":"Treatment of pulmonary arterial hypertension","volume":"351","author":"Humbert","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.chest.2016.03.007_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test","volume":"166","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.chest.2016.03.007_bib16","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1001\/jama.286.12.1494","article-title":"Comparison of 2 methods for calculating adjusted survival curves from proportional hazards models","volume":"286","author":"Ghali","year":"2001","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.chest.2016.03.007_bib17","first-page":"253","article-title":"Functional analysis of the TGFbeta receptor\/Smad pathway through gene ablation in mice","volume":"44","author":"Goumans","year":"2000","journal-title":"Int J Dev Biol"},{"issue":"25","key":"10.1016\/j.chest.2016.03.007_bib18","doi-asserted-by":"crossref","first-page":"16985","DOI":"10.1016\/S0021-9258(17)32506-1","article-title":"Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4","volume":"269","author":"ten Dijke","year":"1994","journal-title":"J\u00a0Biol Chem"},{"issue":"8","key":"10.1016\/j.chest.2016.03.007_bib19","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1515\/BC.2001.149","article-title":"Cooperativity of binding epitopes and receptor chains in the BMP\/TGFbeta superfamily","volume":"382","author":"Knaus","year":"2001","journal-title":"Biol Chem"},{"issue":"7","key":"10.1016\/j.chest.2016.03.007_bib20","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1074\/jbc.M102750200","article-title":"The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways","volume":"277","author":"Nohe","year":"2002","journal-title":"J\u00a0Biol Chem"},{"issue":"26","key":"10.1016\/j.chest.2016.03.007_bib21","doi-asserted-by":"crossref","first-page":"24443","DOI":"10.1074\/jbc.M502825200","article-title":"Bone morphogenetic protein (BMP) type II receptor deletion reveals BMP ligand-specific gain of signaling in pulmonary artery smooth muscle cells","volume":"280","author":"Yu","year":"2005","journal-title":"J\u00a0Biol Chem"},{"issue":"10","key":"10.1016\/j.chest.2016.03.007_bib22","doi-asserted-by":"crossref","first-page":"e76947","DOI":"10.1371\/journal.pone.0076947","article-title":"Deletion of the sequence encoding the tail domain of the bone morphogenetic protein type 2 receptor reveals a bone morphogenetic protein 7-specific gain\u00a0of\u00a0function","volume":"8","author":"Leyton","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.chest.2016.03.007_bib23","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nm.3877","article-title":"Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension","volume":"21","author":"Long","year":"2015","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.chest.2016.03.007_bib24","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1165\/rcmb.2013-0100OC","article-title":"Correction of nonsense BMPR2 and SMAD9 mutations by ataluren in pulmonary arterial hypertension","volume":"49","author":"Drake","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"9","key":"10.1016\/j.chest.2016.03.007_bib25","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/CIRCULATIONAHA.109.933762","article-title":"Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension","volume":"122","author":"Soon","year":"2010","journal-title":"Circulation"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216416454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216416454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T07:28:44Z","timestamp":1757921324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369216416454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0012369216416454"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2016.03.007","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated Levels of Circulating Bone Morphogenetic Protein 7 Predict Mortality in Pulmonary Arterial Hypertension","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2016.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}